Short-term evaluation of the adjustable bulbourethral male sling for post-prostatectomy urinary incontinence.


Journal

Lower urinary tract symptoms
ISSN: 1757-5672
Titre abrégé: Low Urin Tract Symptoms
Pays: Australia
ID NLM: 101506777

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 26 09 2017
revised: 09 03 2018
accepted: 23 04 2018
pubmed: 6 6 2018
medline: 18 12 2019
entrez: 6 6 2018
Statut: ppublish

Résumé

The Argus perineal sling is a minimally invasive surgical option to treat post-prostatectomy stress urinary incontinence (PPSUI). This study retrospectively evaluated the short-term clinical outcomes with the Argus sling for PPSUI management and determined the effects of potential preoperative parameters on intraoperative retrograde leak point pressure (RLPP). In this retrospective review of 16 men with various degrees of stress incontinence after prostatic surgery who underwent Argus sling, PPSUI was evaluated by pad usage, urodynamics, 24-hour pad weight, and validated questionnaires. Findings before and a minimum of 6 months after sling placement were compared. "Cure" was defined as no pad usage or the use of 1 pad for security; "improvement" was defined as a reduction in daily pad use by >50%. After a mean (±SD) follow-up of 9.75 ± 3.51 months, 62.5% of patients were cured, 18.75% were improved, and 18.75% were still incontinent. Preoperative 24-hour pad weight was positively correlated with RLPP (P = .0121, r = 0.6286). Mean RLPP was 37.93 ± 3.45 cmH The Argus male sling can lead to satisfactory results in carefully selected patients. Increased stress urinary incontinence severity based on 24-hour pad weight required higher RLPP to achieve continence. Favorable satisfaction variables and quality of life scores are affected by appropriate intraoperative tensioning pressure.

Identifiants

pubmed: 29869450
doi: 10.1111/luts.12227
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

O111-O116

Informations de copyright

© 2018 John Wiley & Sons Australia, Ltd.

Auteurs

Samer Shamout (S)

Division of Urology, Department of Surgery, Jewish General Hospital, McGill University, Montreal, Canada.

Yu Qing Huang (YQ)

Faculty of Medicine, McGill University, Montreal, Canada.

Hani Kabbara (H)

StatRAC Statistical Research and Analysis Consultancy Firm, Montreal, Canada.

Jacques Corcos (J)

Division of Urology, Department of Surgery, Jewish General Hospital, McGill University, Montreal, Canada.

Lysanne Campeau (L)

Division of Urology, Department of Surgery, Jewish General Hospital, McGill University, Montreal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH